About COBAPHARMA
COBAPHARMA was established in 2011 in Barcelona, Spain, where operations in the pharmaceutical sector are based. Pharmaceutical products are manufactured as the core activity, with focus placed on production processes within the healthcare industry. The companys domain, cobapharma.com, is maintained for online accessibility. Geographic emphasis is given to Spanish markets, supporting medication development and supply needs in the region.
- Headquarter Barcelona, Spain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cobapharma S.L.U.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of COBAPHARMA
Detailed funding history for COBAPHARMA
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in COBAPHARMA
COBAPHARMA has secured backing from 1 investor. Prominent investors backing the company include IMCD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Speciality chemicals and food ingredients are distributed by IMCD.
|
Locked | Locked | Locked |
Investor details for COBAPHARMA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by COBAPHARMA
Investment portfolio details for COBAPHARMA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - COBAPHARMA
Detailed financials for COBAPHARMA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cobapharma Comparisons
Peer comparison for COBAPHARMA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of COBAPHARMA
Detailed competitors of COBAPHARMA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cobapharma
Complete news archive for COBAPHARMA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about COBAPHARMA
COBAPHARMA was founded in 2011.
COBAPHARMA is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
COBAPHARMA was established in 2011 in Barcelona, Spain, where operations in the pharmaceutical sector are based. Pharmaceutical products are manufactured as the core activity, with focus placed on production processes within the healthcare industry. The companys domain, cobapharma.com, is maintained for online accessibility. Geographic emphasis is given to Spanish markets, supporting medication development and supply needs in the region.
COBAPHARMA has 1 investor. Key investors include IMCD.